pipeline-prospector-insert
X

Overview of Diazepam

Client Email Product
Tox21_202458
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

API Market Place

INTERMEDIATES
DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

0

SERVICES

0

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Coating
Ingredient(s): HPMC Based Granules
Dosage Form: Granule / Pellet, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph.Eur, USP-NF
Technical Specifications: EXCiPACT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Coating
Ingredient(s): HPMC Based Granules
Dosage Form: Granule / Pellet, Tablet
More Info on Category: Coating Systems & Additives
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: EXCiPACT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Coating, Moisture Protection
Ingredient(s): HPMC Based Granules
More Info on Category: Coating Systems & Additives
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph.Eur, USP-NF, JPE
Technical Specifications: EXCiPACT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Coating
Ingredient(s): HPMC Based Granules
Dosage Form: Granule / Pellet, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph.Eur, USP-NF
Technical Specifications: EXCiPACT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Coating
Dosage Form: Tablet
More Info on Category: Coating Systems & Additives
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: EXCiPACT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Coloring Agents
Ingredient(s): HPMC Based Granules
Dosage Form: Tablet
More Info on Category: Coating Systems & Additives
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Ph.Eur, USP-NF
Technical Specifications: EXCiPACT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Capsule Filling, Direct Compression, Binding, Disintegration
More Info on Category: Direct Compression
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: EXCiPACT
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • TABLET;ORAL - 10MG
  • TABLET;ORAL - 2MG
  • TABLET;ORAL - 5MG
  • GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • GEL;RECTAL - 2.5MG/0.5ML (5MG/ML)
  • GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • SPRAY;NASAL - 10MG/SPRAY
  • SPRAY;NASAL - 5MG/SPRAY
  • SPRAY;NASAL - 7.5MG/SPRAY
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty

Advertise With Us

Advertise With Us